Cypress Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.1M | Sell |
46,836
-1,962
| -4% | -$1.99M | 4.85% | 2 |
|
|
2025
Q4 | $52.4M | Sell |
48,798
-2,614
| -5% | -$2.5M | 5.88% | 2 |
|
|
2025
Q3 | $39.2M | Sell |
51,412
-673
| -1% | -$501K | 4.69% | 2 |
|
|
2025
Q2 | $40.6M | Sell |
52,085
-285
| -0.5% | -$221K | 5.05% | 3 |
|
|
2025
Q1 | $43.3M | Sell |
52,370
-1,443
| -3% | -$1.2M | 5.66% | 3 |
|
|
2024
Q4 | $41.5M | Sell |
53,813
-1,035
| -2% | -$857K | 5.1% | 3 |
|
|
2024
Q3 | $48.6M | Sell |
54,848
-1,417
| -3% | -$1.27M | 5.46% | 3 |
|
|
2024
Q2 | $50.9M | Sell |
56,265
-2,171
| -4% | -$1.74M | 6.1% | 1 |
|
|
2024
Q1 | $45.5M | Buy |
58,436
+524
| +0.9% | +$373K | 5.45% | 2 |
|
|
2023
Q4 | $33.8M | Sell |
57,912
-2,112
| -4% | -$1.23M | 4.39% | 3 |
|
|
2023
Q3 | $32.2M | Sell |
60,024
-991
| -2% | -$511K | 4.66% | 2 |
|
|
2023
Q2 | $28.6M | Sell |
61,015
-503
| -0.8% | -$211K | 4.14% | 2 |
|
|
2023
Q1 | $21.1M | Sell |
61,518
-8,654
| -12% | -$2.92M | 3.24% | 3 |
|
|
2022
Q4 | $25.7M | Sell |
70,172
-3,139
| -4% | -$1.11M | 3.87% | 2 |
|
|
2022
Q3 | $23.7M | Sell |
73,311
-2,951
| -4% | -$935K | 3.95% | 2 |
|
|
2022
Q2 | $24.7M | Sell |
76,262
-4,324
| -5% | -$1.3M | 3.77% | 2 |
|
|
2022
Q1 | $23.1M | Sell |
80,586
-229
| -0.3% | -$58.9K | 2.84% | 3 |
|
|
2021
Q4 | $22.3M | Sell |
80,815
-805
| -1% | -$204K | 2.8% | 3 |
|
|
2021
Q3 | $18.9M | Sell |
81,620
-515
| -0.6% | -$127K | 2.56% | 4 |
|
|
2021
Q2 | $18.9M | Sell |
82,135
-482
| -0.6% | -$96.8K | 2.55% | 4 |
|
|
2021
Q1 | $15.4M | Sell |
82,617
-994
| -1% | -$194K | 2.19% | 6 |
|
|
2020
Q4 | $14.1M | Buy |
83,611
+1,908
| +2% | +$285K | 2.13% | 7 |
|
|
2020
Q3 | $12.1M | Sell |
81,703
-730
| -0.9% | -$113K | 2.01% | 7 |
|
|
2020
Q2 | $13.5M | Sell |
82,433
-629
| -0.8% | -$96.6K | 2.48% | 6 |
|
|
2020
Q1 | $11.5M | Sell |
83,062
-2,960
| -3% | -$407K | 2.66% | 5 |
|
|
2019
Q4 | $11.3M | Buy |
86,022
+14
| +0% | +$1.62K | 2.01% | 10 |
|
|
2019
Q3 | $9.62M | Sell |
86,008
-895
| -1% | -$99.6K | 1.85% | 12 |
|
|
2019
Q2 | $9.63M | Buy |
86,903
+2,002
| +2% | +$236K | 1.9% | 10 |
|
|
2019
Q1 | $11M | Sell |
84,901
-1,943
| -2% | -$236K | 2.26% | 6 |
|
|
2018
Q4 | $10M | Buy |
86,844
+4,602
| +6% | +$514K | 2.3% | 6 |
|
|
2018
Q3 | $8.83M | Buy |
82,242
+561
| +0.7% | +$56.1K | 1.67% | 12 |
|
|
2018
Q2 | $6.97M | Buy |
81,681
+650
| +0.8% | +$53.4K | 1.44% | 17 |
|
|
2018
Q1 | $6.27M | Sell |
81,031
-3,586
| -4% | -$289K | 1.32% | 21 |
|
|
2017
Q4 | $7.15M | Sell |
84,617
-3,104
| -4% | -$264K | 1.49% | 19 |
|
|
2017
Q3 | $7.5M | Sell |
87,721
-590
| -0.7% | -$48.4K | 1.6% | 14 |
|
|
2017
Q2 | $7.27M | Sell |
88,311
-1,750
| -2% | -$143K | 1.61% | 14 |
|
|
2017
Q1 | $7.58M | Buy |
90,061
+3,058
| +4% | +$245K | 1.77% | 14 |
|
|
2016
Q4 | $6.4M | Buy |
87,003
+2,212
| +3% | +$165K | 1.52% | 20 |
|
|
2016
Q3 | $6.8M | Sell |
84,791
-1,100
| -1% | -$88K | 1.62% | 20 |
|
|
2016
Q2 | $6.76M | Sell |
85,891
-1,127
| -1% | -$84.8K | 1.58% | 20 |
|
|
2016
Q1 | $6.27M | Sell |
87,018
-2,012
| -2% | -$152K | 1.54% | 21 |
|
|
2015
Q4 | $7.5M | Buy |
89,030
+5,875
| +7% | +$488K | 1.81% | 15 |
|
|
2015
Q3 | $6.96M | Sell |
83,155
-125
| -0.2% | -$10.6K | 1.72% | 17 |
|
|
2015
Q2 | $6.95M | Buy |
83,280
+414
| +0.5% | +$31.5K | 1.6% | 18 |
|
|
2015
Q1 | $6.02M | Sell |
82,866
-3,104
| -4% | -$221K | 1.37% | 22 |
|
|
2014
Q4 | $5.93M | Buy |
85,970
+394
| +0.5% | +$26.6K | 1.37% | 23 |
|
|
2014
Q3 | $5.55M | Buy |
85,576
+820
| +1% | +$51.9K | 1.32% | 24 |
|
|
2014
Q2 | $5.27M | Buy |
84,756
+3,716
| +5% | +$222K | 1.24% | 27 |
|
|
2014
Q1 | $4.77M | Sell |
81,040
-1,870
| -2% | -$104K | 1.17% | 29 |
|
|
2013
Q4 | $4.23M | Sell |
82,910
-7,000
| -8% | -$351K | 1.04% | 33 |
|
|
2013
Q3 | $4.53M | Sell |
89,910
-26,750
| -23% | -$1.4M | 1.12% | 32 |
|
|
2013
Q2 | $5.73M | Buy |
+116,660
| New | +$6.35M | 1.2% | 25 |
|
Other funds holding LLY
VCM
VPM
Cypress Capital Group's LLY Position: Q1 2026 in Review
Cypress Capital Group reduced its Eli Lilly (LLY) stake by 4% in Q1 2026, selling an estimated $1.99M and leaving 46,836 shares worth $43.1M. The position accounts for 4.85% of the portfolio, ranked #2.
Cypress Capital Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Cypress Capital Group held 46,836 shares of Eli Lilly worth $43.1M as of Q1 2026.
- Cypress Capital Group sold 1,962 Eli Lilly shares in Q1 2026, an estimated $1.99M.
- Eli Lilly made up 4.85% of Cypress Capital Group's portfolio in Q1 2026, its #2 holding.
- Cypress Capital Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Cypress Capital Group's Eli Lilly position peaked at $52.4M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Cypress Capital Group's 13F filing for Q1 2026, filed 15 May 2026.